Statistics
Publications
17
Citations
899
H-Index
14
Active since
2007
Tim Kong is an author at Washington University in St. Louis specializing in oncology, medicine, and molecular oncology.
Publications per year
2007–2025
17
17
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
Yibo Xue, Brian Meehan, Zheng Qing Fu et al. · Nature Communications · 2019 · 189 citations · Full text
CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers
Tim Kong, Ryuhjin Ahn, Kangning Yang et al. · Cancer Research · 2019 · 162 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 17